A novel pharmaceutical composition based on a reverse transcriptase inhibitor and meldonium.Melting Point:87-92°CSolubility:Methanol, WaterMethod for Determining Identity: Proton NMR (D2O) and MSTLC Conditions: C18; Acetonitrile : Water: Ammonium Hydroxide (6 : 4: 0.1). Visualized with KMnO4 and Ninhydrin (single spot; Rf = 0.45). Water Content: 20.4% (Karl Fischer)Storage and Stability:Store at 4°C. Caution: Hygroscopic; store under inert atmosphere. For maximum recovery of product, centrifuge the original vial prior to removing the cap.